companyprofile
Actions
Canadian Medical Center Co.
- Main Market
- Health Care Equipment & Svc
- Shares Type
- Common Shares
Stats Overview
-
Prev. Close 6.47
-
Open 6.45
-
High 6.70
-
Low 6.38
-
YTD% Change8.18
-
No. of Trades 490
-
Avg. Trade size* 847
-
Volume Traded 414,942
-
Value Traded (^) 2,727,760.33
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 17/08/2025 | 12/10/2025 | 26/10/2025 | Account Transfer | ^0.05 |
| 18/03/2025 | 11/05/2025 | 25/05/2025 | Account Transfer | ^0.05 |
| 26/03/2024 | 05/05/2024 | 21/05/2024 | Account Transfer | ^0.09 |
| 13/08/2023 | 27/08/2023 | 12/09/2023 | Account Transfer | ^0.10 |
| 19/03/2023 | 30/03/2023 | 13/04/2023 | Account Transfer | ^0.50 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2024-12-31 | 2023-12-31 | ||
|---|---|---|---|---|
| Total Assets |
119,875
|
112,253
|
- | - |
| Total Liabilities |
26,006
|
20,424
|
- | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
93,869
|
91,829
|
- | - |
| Total Liabilities and Shareholders Equity |
119,875
|
112,253
|
- | - |
| Statement of Income | 2024-12-31 | 2023-12-31 | ||
| Total Revenue (Sales/Operating) |
110,803
|
100,342
|
- | - |
| Net Profit (Loss) before Zakat and Tax |
12,894
|
17,862
|
- | - |
| Zakat and Income Tax |
-2,625
|
-2,152
|
- | - |
| Net Profit (Loss) Attributable to Shareholders of the Issuer |
10,269
|
15,710
|
- | - |
| Total Comprehensive Income Attributable to Shareholders of the Issuer |
8,971
|
16,369
|
- | - |
| Profit (Loss) per Share |
0.13
|
0.2
|
- | - |
| Cash Flows | 2024-12-31 | 2023-12-31 | ||
| Net Cash From Operating Activities |
4,134
|
12,766
|
- | - |
| Net Cash From Investing Activities |
-42,921
|
42,630
|
- | - |
| Net Cash From Financing Activities |
-9,914
|
-12,690
|
- | - |
| Cash and Cash Equivalents, Beginning of the Period |
53,361
|
10,655
|
- | - |
| Cash and Cash Equivalents, End of the Period |
4,660
|
53,361
|
- | - |
| All Figures in | Thousands | Thousands | ||
| All Currency In | ^ | ^ | ||
| Last Update Date | 2025-03-24 | 2024-04-01 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2025-09-30 | |||
|---|---|---|---|---|
| Total Assets |
130,924
|
|||
| Total Liabilities |
33,753
|
|||
| Total Shareholders Equity (After Deducting the Minority Equity) |
97,171
|
|||
| Total Liabilities and Shareholders Equity |
130,924
|
|||
| Statement of Income | 2025-09-30 | |||
| Total Revenue (Sales/Operating) |
41,688
|
|||
| Net Profit (Loss) before Zakat and Tax |
3,999
|
|||
| Zakat and Income Tax |
-514
|
|||
| Net Profit (Loss) Attributable to Shareholders of the Issuer |
3,485
|
|||
| Total Comprehensive Income Attributable to Shareholders of the Issuer |
3,216
|
|||
| Profit (Loss) per Share |
0.05
|
|||
| Cash Flows | 2025-09-30 | |||
| Net Cash From Operating Activities |
9,402
|
|||
| Net Cash From Investing Activities |
-6,927
|
|||
| Net Cash From Financing Activities |
-6,346
|
|||
| Cash and Cash Equivalents, Beginning of the Period |
4,660
|
|||
| Cash and Cash Equivalents, End of the Period |
789
|
|||
| All Figures in | Thousands | |||
| All Currency In | ^ | |||
| Last Update Date | 2025-11-06 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Peer Comparison
Note:Display data relevant only to the corresponding class of shares only
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
The company operates in the health sector in the Kingdom of Saudi Arabia, and the company''s business falls under two main categories, medical centers and recognized health care provider for oil and gas industries.
Company History
Canadian General Medical Center Complex Company was established as a branch of a sole proprietorship in 2008 and during 2016, the company was transferred into a limited liability company and then into a closed joint stock company in 2020 under Ministerial Resolution No. (159) and under Commercial Registration No. (2050058605) on 06/28/ 2021 The Capital Market announced the approval of the registration of its shares for the purpose of listing, and consequently its transformation into a joint stock company listed on the Saudi Stock Exchange.
Company Bylaws
Equity Profile
- Authorized Capital (^) 77,000,000
- Total Issued Shares 77,000,000
- Paid Capital (^) 77,000,000
- Par Value/Share 1
- Paid Up Value/Share 1
Last Update :2023-06-21
Investment limits
There are no investment limits on the company s Shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors ownership in Listed Companies based on Company s bylaw and the issued instructions by the related regulators and supervisory authorities
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Manar Othman ALdokhi
Company Address:
Omar bin al Khattab Street- Uhud - Dammam
Contact Details:
Telephone:
0138188320
Fax
: 0138188059
Email
: m.aldokhi@canadian-mc.com
Company Website:
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}